S 773 New Jersey Senate · 2026-2027 Regular Session

Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.

This bill increases annual funding for cancer research in New Jersey by directing $10 million in cigarette and tobacco tax revenues to the New Jersey Commission on Cancer Research (NJCCR), up from the current $1 million. It establishes a permanent, non-lapsing "Cancer Research Fund" in the state Treasury, ensuring these funds cannot be diverted to other state budgets. The fund must allocate at least $5 million annually to general cancer research and at least $5 million specifically to pediatric cancer research, with all spending requiring approval by the NJCCR. The State Treasurer manages the fund, and any interest earned is reinvested into the fund for ongoing research support.

Issues: ✓ Budget & Taxes

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2026

Committee Review

Floor Vote

Governor

Introduced Jan 13, 2026 Last action May 11, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Technical Review Of Prefiled Bill → Introduced · 5 edits · Jan 13, 2026

MODERATE

This is a procedural transition from technical review to formal introduction of S 773, which increases cigarette and tobacco tax revenue allocated to the New Jersey Commission on Cancer Research (NJCCR) from $1 million to $10 million and replaces an existing lapsing fund with a non-lapsing revolving Cancer Research Fund. The added statement section clarifies that at least $5 million must go to general cancer research and at least $5 million to pediatric cancer research, addressing a gap where the NJCCR was only appropriated $4 million in FY 2025 despite statutory requirements.

FISCAL

Increases cigarette and tobacco products tax revenue provided to NJCCR from $1 million to $10 million annually.

Replaces the existing lapsing Cancer Research Fund with a non-lapsing, revolving fund within the Department of the Treasury, ensuring funds are not transferred to the General Fund as has occurred in recent years.

REQUIREMENT

Requires that at least $5 million of the fund be used for general cancer research and at least $5 million for pediatric cancer research.

ENFORCEMENT

Designates the State Treasurer as custodian of the fund, with disbursements made only upon vouchers signed by the NJCCR chairperson or designee. Monies are to be invested by the Director of the Division of Investment and interest credited back to the fund.

SCOPE

The list of sponsoring senators was reduced from 24 to 13, removing Bramnick, Schepisi, Burgess, Steinhardt, Ruiz, Johnson, Stack, Amato, Gopal, Moriarty, Pennacchio, McKnight, and Henry.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

May 11, 2026

Committee

Referred to Senate Budget and Appropriations Committee

upper

Jan 13, 2026

Introduced

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

upper

2 primary · 18 co-sponsors